BACKGROUND AND OBJECTIVES: Radio frequency identification (RFID) can be a key enabler for enhancing productivity and safety of the blood product supply chain. This article describes a systematic approach developed by the RFID Blood Consortium for a comprehensive feasibility and impact assessment of RFID application in blood centre operations. MATERIALS AND METHODS: Our comprehensive assessment approach incorporates process-orientated and technological perspectives as well as impact analysis. Assessment of RFID-enabled process redesign is based on generic core processes derived from the three participating blood centres. The technological assessment includes RFID tag readability and performance evaluation, testing of temperature and biological effects of RF energy on blood products, and RFID system architecture design and standards. The scope of this article is limited to blood centre processes (from donation to manufacturing/distribution) for selected mainstream blood products (red blood cells and platelets). RESULTS: Radio frequency identification can help overcome a number of common challenges and process inefficiencies associated with identification and tracking of blood products. High frequency-based RFID technology performs adequately and safely for red blood cell and platelet products. Productivity and quality improvements in RFID-enabled blood centre processes can recoup investment cost in a 4-year payback period. CONCLUSION: Radio frequency identification application has significant process-orientated and technological implications. It is feasible and economically justifiable to incorporate RFID into blood centre processes.
BACKGROUND AND OBJECTIVES: Radio frequency identification (RFID) can be a key enabler for enhancing productivity and safety of the blood product supply chain. This article describes a systematic approach developed by the RFID Blood Consortium for a comprehensive feasibility and impact assessment of RFID application in blood centre operations. MATERIALS AND METHODS: Our comprehensive assessment approach incorporates process-orientated and technological perspectives as well as impact analysis. Assessment of RFID-enabled process redesign is based on generic core processes derived from the three participating blood centres. The technological assessment includes RFID tag readability and performance evaluation, testing of temperature and biological effects of RF energy on blood products, and RFID system architecture design and standards. The scope of this article is limited to blood centre processes (from donation to manufacturing/distribution) for selected mainstream blood products (red blood cells and platelets). RESULTS: Radio frequency identification can help overcome a number of common challenges and process inefficiencies associated with identification and tracking of blood products. High frequency-based RFID technology performs adequately and safely for red blood cell and platelet products. Productivity and quality improvements in RFID-enabled blood centre processes can recoup investment cost in a 4-year payback period. CONCLUSION: Radio frequency identification application has significant process-orientated and technological implications. It is feasible and economically justifiable to incorporate RFID into blood centre processes.
Authors: Víctor M Alonso Rorís; Juan M Santos Gago; Luis Álvarez Sabucedo; Mateo Ramos Merino; Javier Sanz Valero Journal: J Med Syst Date: 2016-09-13 Impact factor: 4.460
Authors: A C P Guédon; L S G L Wauben; D F de Korne; M Overvelde; J Dankelman; J J van den Dobbelsteen Journal: J Med Syst Date: 2014-12-14 Impact factor: 4.460
Authors: Timo Stübig; Eduardo Suero; Christian Zeckey; William Min; Laura Janzen; Musa Citak; Christian Krettek; Tobias Hüfner; Ralph Gaulke Journal: J Am Med Inform Assoc Date: 2013-05-15 Impact factor: 4.497
Authors: Gert Reiter; Ursula Reiter; Thomas Wagner; Noemi Kozma; Jörg Roland; Helmut Schöllnast; Franz Ebner; Gerhard Lanzer Journal: PLoS One Date: 2013-02-28 Impact factor: 3.240